Literature DB >> 23828138

Interleukin-21-mediated TLR4 activation in celiac disease.

Se Jin Park, Jae Il Shin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23828138     DOI： 10.1007/s10620-013-2738-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

Authors:  Lars-Egil Fallang; Elin Bergseng; Kinya Hotta; Axel Berg-Larsen; Chu-Young Kim; Ludvig M Sollid
Journal:  Nat Immunol       Date:  2009-08-30       Impact factor: 25.606

2.  HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22.

Authors:  M Bodd; M Ráki; S Tollefsen; L E Fallang; E Bergseng; K E A Lundin; L M Sollid
Journal:  Mucosal Immunol       Date:  2010-06-23       Impact factor: 7.313

3.  Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation.

Authors:  Joseph M Reynolds; Gustavo J Martinez; Yeonseok Chung; Chen Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease.

Authors:  D Fina; M Sarra; R Caruso; G Del Vecchio Blanco; F Pallone; T T MacDonald; G Monteleone
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

5.  IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.

Authors:  Mari Strengell; Anne Lehtonen; Sampsa Matikainen; Ilkka Julkunen
Journal:  J Leukoc Biol       Date:  2006-03-21       Impact factor: 4.962

6.  Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.

Authors:  Noemí Eiró; Salomé González-Reyes; Lucía González; Luis O González; Antonio Altadill; Alejandro Andicoechea; Manuel F Fresno-Forcelledo; Luis Rodrigo-Sáez; F J Vizoso
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

7.  A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.

Authors:  David A van Heel; Lude Franke; Karen A Hunt; Rhian Gwilliam; Alexandra Zhernakova; Mike Inouye; Martin C Wapenaar; Martin C N M Barnardo; Graeme Bethel; Geoffrey K T Holmes; Con Feighery; Derek Jewell; Dermot Kelleher; Parveen Kumar; Simon Travis; Julian R F Walters; David S Sanders; Peter Howdle; Jill Swift; Raymond J Playford; William M McLaren; M Luisa Mearin; Chris J Mulder; Ross McManus; Ralph McGinnis; Lon R Cardon; Panos Deloukas; Cisca Wijmenga
Journal:  Nat Genet       Date:  2007-06-10       Impact factor: 38.330

8.  Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4.

Authors:  Yvonne Junker; Sebastian Zeissig; Seong-Jun Kim; Donatella Barisani; Herbert Wieser; Daniel A Leffler; Victor Zevallos; Towia A Libermann; Simon Dillon; Tobias L Freitag; Ciaran P Kelly; Detlef Schuppan
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.